Organization · Venture Capital
Convergent Ventures
Convergent Ventures is an early-stage venture capital firm based in San Francisco and New York City, focusing on investments in technologies that enhance human and planetary health. They target seed-stage companies at the intersection of data and the natural sciences.
Overview
What Convergent Ventures does
What Convergent Ventures is
Convergent Ventures is an early-stage venture capital firm based in San Francisco and New York City, focusing on investments in technologies that enhance human and planetary health. They target seed-stage companies at the intersection of data and the natural sciences.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find Convergent Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Convergent Ventures as a funder
Investment thesis
Convergent Ventures invests at the intersection of data and the natural, physical, and human sciences, focusing on technologies that improve human and planetary health. They seek differentiated technologies with scalable business models that deliver significant societal impacts and financial returns.
Focus narrative
Convergent Ventures targets differentiated technologies at the intersection of data and the natural, physical, and human sciences. They emphasize collaboration with multiple investors to enhance market and technical expertise, aiming for scalable business models that can deliver significant societal impacts and financial returns.
Value beyond capital
Convergent Ventures provides value beyond capital by offering technical diligence, commercialization support, strategic introductions, business coaching, and assistance with follow-on fundraising. They aim to empower founders with the resources and expertise needed to succeed in their ventures.
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Angel · Accelerator
- Sectors
- Healthcare · Biotech · Climate · AI · Diagnostics · Medical Devices · Energy · Food and AgTech · Frontier
- Regions
- North America · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Valence and Totient
Portfolio context
Notable portfolio companies include: Ubicept: Develops photon fusion technology to enhance vehicle safety systems. Novamera: Focuses on breakthrough surgical mining technology for the production of critical minerals and metals. Biotia: Partners with healthcare institutions for AI-driven orthopedic diagnostics. FIGUR8: Engages in health monitoring and diagnostics. Dandelion Health: Works on innovative health solutions. Contraline: Develops a novel hydrogel platform for long-lasting, reversible contraception.
Common questions
What to know about Convergent Ventures
Upseed classifies Convergent Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.